|1 Table of Contents 3
|1.1 List of Tables 10
|1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Anesthesia and Respiratory Devices Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 15
3 Anesthesia and Respiratory Devices Market, United States 22
3.1 Anesthesia and Respiratory Devices Market, United States, Revenue ($m), 2018-2033 22
3.2 Anesthesia and Respiratory Devices Market, United States, Revenue Mix ($m), 2023 24
3.3 Anesthesia and Respiratory Devices Market, United States, Category Contribution by Revenue ($m), 2023 25
3.4 Anesthesia and Respiratory Devices Market, United States, Revenue ($m), 2018-2033 26
3.5 Anesthesia and Respiratory Devices Market, United States, Volume (Units), 2018-2033 28
3.6 Anesthesia and Respiratory Devices Market, United States, Volume (Units), 2018-2033 29
3.7 Anesthesia and Respiratory Devices Market, United States, Company Share by Revenue ($m), 2023 31
4 Airway Management Market, United States 33
4.1 Airway Management Market, United States, Revenue Mix ($m), 2023 33
4.2 Airway Management Market, United States, Segment Contribution (%), 2023 34
4.3 Airway Management Market, United States, Revenue ($m), 2018-2033 35
4.3.1 Airway Management Masks Market, United States, Revenue ($m), by Segment, 2018-2033 37
4.3.2 Airway Management Tubes Market, United States, Revenue ($m), by Segment, 2018-2033 38
4.3.3 Intubation Accessories Market, United States, Revenue ($m), by Segment, 2018-2033 40
4.4 Airway Management Market, United States, Volume (Units), 2018-2033 42
4.4.1 Airway Management Masks Market, United States, Volume (Units), by Segment, 2018-2033 44
4.4.2 Airway Management Tubes Market, United States, Volume (Units), by Segment, 2018-2033 46
4.4.3 Intubation Accessories Market, United States, Volume (Units), by Segment, 2018-2033 48
4.5 Airway Management Market, United States, Average Price ($), 2018-2033 50
4.6 Airway Management Market, United States, Distribution Share by Revenue ($m), 2023 52
4.7 Airway Management Market, United States, Company Share by Revenue ($m), 2023 53
5 Anesthesia Devices Market, United States 55
5.1 Anesthesia Devices Market, United States, Revenue Mix ($m), 2023 55
5.2 Anesthesia Devices Market, United States, Segment Contribution (%), 2023 56
5.3 Anesthesia Devices Market, United States, Revenue ($m), 2018-2033 57
5.3.1 Anesthesia Circuits Market, United States, Revenue ($m), by Segment, 2018-2033 59
5.3.2 Anesthesia Machines Market, United States, Revenue ($m), by Segment, 2018-2033 61
5.3.3 Regional Anesthesia Disposables Market, United States, Revenue ($m), by Segment, 2018-2033 63
5.4 Anesthesia Devices Market, United States, Volume (Units), 2018-2033 65
5.4.1 Anesthesia Circuits Market, United States, Volume (Units), by Segment, 2018-2033 68
5.4.2 Anesthesia Machines Market, United States, Volume (Units), by Segment, 2018-2033 70
5.4.3 Regional Anesthesia Disposables Market, United States, Volume (Units), by Segment, 2018-2033 72
5.5 Anesthesia Devices Market, United States, Average Price ($), 2018-2033 75
5.6 Anesthesia Devices Market, United States, Distribution Share by Revenue ($m), 2023 77
5.7 Anesthesia Devices Market, United States, Company Share by Revenue ($m), 2023 78
6 Respiratory Devices Market, United States 80
6.1 Respiratory Devices Market, United States, Revenue Mix ($m), 2023 80
6.2 Respiratory Devices Market, United States, Segment Contribution (%), 2023 81
6.3 Respiratory Devices Market, United States, Revenue ($m), 2018-2033 82
6.3.1 Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), by Segment, 2018-2033 84
6.3.2 Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2018-2033 86
6.3.3 Respiratory Device Accessories Market, United States, Revenue ($m), by Segment, 2018-2033 88
6.3.4 Ventilators Market, United States, Revenue ($m), by Segment, 2018-2033 90
6.4 Respiratory Devices Market, United States, Volume (Units), 2018-2033 92
6.4.1 Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), by Segment, 2018-2033 95
6.4.2 Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2018-2033 97
6.4.3 Respiratory Device Accessories Market, United States, Volume (Units), by Segment, 2018-2033 99
6.4.4 Ventilators Market, United States, Volume (Units), by Segment, 2018-2033 102
6.5 Respiratory Devices Market, United States, Average Price ($) , 2018-2033 104
6.6 Respiratory Devices Market, United States, Distribution Share by Revenue ($m), 2023 106
6.7 Respiratory Devices Market, United States, Company Share by Revenue ($m), 2023 107
7 Overview of Key Companies in United States, Anesthesia and Respiratory Devices Market 109
7.1 Medtronic Plc 109
7.1.1 Company Overview 109
7.2 Teleflex Inc 109
7.2.1 Company Overview 109
7.3 ResMed Inc 109
7.3.1 Company Overview 109
7.4 GE HealthCare Technologies Inc 110
7.4.1 Company Overview 110
7.5 Philips Respironics Inc 110
7.5.1 Company Overview 110
7.6 Dragerwerk AG & Co KGaA 110
7.6.1 Company Overview 110
7.7 ICU Medical Inc 110
7.7.1 Company Overview 110
7.8 Ambu A/S 111
7.8.1 Company Overview 111
7.9 Fisher & Paykel Healthcare Corporation Ltd 111
7.9.1 Company Overview 111
7.10 Vyaire Medical Inc 111
7.10.1 Company Overview 111
7.11 B. Braun Melsungen AG 111
7.11.1 Company Overview 111
7.12 Koninklijke Philips NV 111
7.12.1 Company Overview 111
8 Anesthesia and Respiratory Devices Market Pipeline Products 112
9 Financial Deals Landscape 114
9.1 Acquisition 114
9.1.1 Wellinks Acquires Spire Health 114
9.1.2 Vitalograph Acquires Morgan Scientific 116
9.1.3 Stryker Acquires NICO 117
9.1.4 DERM-JES Holdings Acquires DermTech 118
9.1.5 Owens & Minor to Acquire Rotech Healthcare Holdings for USD1.36 Billion 119
9.1.6 Smiths Group Sells
4.9% Stake in ICU Medical For USD152 Million 121
9.1.7 Nordson Acquires Atrion For USD800 Million 122
9.1.8 Stereotaxis to Acquire Access Point Technologies 124
9.2 Asset Transactions 125
9.2.1 Trudell Medical to Acquire RDx Business Unit from Vyaire Medical 125
9.2.2 Zoll Medical Acquires Ventilator Business from Vyaire Medical 126
9.3 Debt Offerings 128
9.3.1 Philip Morris International Raises USD750 Million in Public Offering of
4.625% Notes Due 2029 128
9.3.2 Philip Morris International Raises USD750 Million in Public Offering of
4.375% notes due 2027 130
9.3.3 Philip Morris International Raises USD750 Million in Public Offering of
4.750% Notes Due 2031 132
9.3.4 Philip Morris International Raises USD750 Million in Public Offering of
4.900% Notes Due 2034 134
9.3.5 MedShift Raises USD289.5 Million in Debt Financing 136
9.3.6 Scilex Holding Raises USD50 Million in Private Placement of
5.5% Notes Due 2026 137
9.3.7 Eli Lilly Raises USD750 Million in Public Offering of
4.150% Notes due 2027 139
9.3.8 Eli Lilly Raises USD1 Billion in Public Offering of
4.2% Notes due 2029 141
10 Recent Developments 142
10.1 Corporate Communications 142
10.1.1 Feb 21, 2025: Lynx Dx launches MPS2 prostate cancer test for at-home collection 142
10.1.2 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 142
10.1.3 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board 143
10.1.4 Feb 03, 2025: Inogen Adds Mira Kirti Sahney to its Board 143
10.1.5 Jan 15, 2025: The University of Florida Appoints Waste Pro Vice President to Advisory Board 144
10.1.6 Dec 12, 2024: Contact Center Technology Pioneer Michael Tessler Joins Glia's Board of Directors 144
10.1.7 Dec 05, 2024: OSI Systems Names Ajay Mehra to Succeed Deepak Chopra as President and CEO 144
10.1.8 Dec 03, 2024: AdaptHealth Announces Appointment of Russell Schuster as Chief Commercial Officer 145
10.1.9 Oct 28, 2024: Electromed Appoints Peter Horwich, Vice President, Marketing 145
10.1.10 Oct 18, 2024: Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors 146
10.1.11 Oct 17, 2024: AdaptHealth Appoints Diana Nole to Board of Directors 146
10.1.12 Oct 04, 2024: Akron Children’s: Gutowski Named Chief Government Relations and Business Development Officer 147
10.1.13 Sep 19, 2024: Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 Cirrus-Hcm Trial in Patients with HCM 147
10.1.14 Sep 19, 2024: ILC Dover's SCape CO/CBRN 30 Escape Respirator Receives CE and UKCA Certification, Setting New Standard for Respiratory Protection 148
10.1.15 Sep 05, 2024: Inogen Names Eric Pauls as Vice President of Sales, North America 149
10.1.16 Sep 05, 2024: General Motors Appoints Alfred Kelly, Jr. to Board of Directors 149
10.1.17 Aug 27, 2024: Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors 149
10.1.18 Aug 26, 2024: AdaptHealth Announces New Chief Operating Officer 150
10.1.19 Aug 15, 2024: ResMed Announces Expansion of Board of Directors 150
10.1.20 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer 151
10.1.21 Jul 24, 2024: Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report 151
10.1.22 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer 152
10.1.23 Jul 01, 2024: AMETEK Names Keith Kowalski as Vice President and General Manager, AMS Division 152
10.1.24 Jun 03, 2024: Kimball Electronics Appoints New Treasurer 152
10.1.25 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition 153
10.1.26 May 13, 2024: NASA Appoints David Salvagnini as Chief Artificial Intelligence Officer 153
10.1.27 May 11, 2024: UNO Appoints Dr. Yu-Che Chen as Interim Director of Public Administration School 154
10.1.28 May 09, 2024: AMETEK Appoints Patrick L. Williams Vice President and General Manager, Maintenance, Repair, Overhaul (MRO) Division 154
10.1.29 May 01, 2024: Detect-ION announces new funding to revolutionize health diagnostics in low-income regions 154
10.2 Financial Announcements 155
10.2.1 Apr 23, 2025: Resmed Announces Results for the Third Quarter of Fiscal Year 2025 155
10.2.2 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 156
10.2.3 Apr 02, 2025: Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 156
10.2.4 Mar 25, 2025: Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update 156
10.2.5 Feb 26, 2025: United Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results 157
10.2.6 Feb 13, 2025: Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information 158
10.2.7 Feb 04, 2025: Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025 158
10.2.8 Feb 04, 2025: AdaptHealth Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call 158
10.2.9 Jan 28, 2025: Electromed Schedules its Second Quarter Fiscal 2025 Financial Results Conference Call for February 11, 2025 at 5:00 p.m. ET 159
10.2.10 Jan 23, 2025: GE Aerospace Announces Fourth Quarter 2024 Results 159
10.2.11 Jan 22, 2025: Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors 160
10.2.12 Jan 16, 2025: Masimo Announces Select Preliminary 2024 Financial Results and 2025 Guidance 160
10.2.13 Jan 09, 2025: ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 160
10.2.14 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30 161
10.2.15 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 161
10.2.16 Nov 25, 2024: Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt 161
10.2.17 Nov 13, 2024: Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update 162
10.2.18 Nov 12, 2024: Electromed Announces Fiscal 2025 First Quarter Financial Results 163
10.2.19 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 163
10.2.20 Nov 12, 2024: Lifeloc Technologies Reports 2024 Third Quarter Results 164
10.2.21 Nov 07, 2024: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results 165
10.2.22 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results 167
10.2.23 Oct 30, 2024: United Therapeutics Reports Third Quarter 2024 Financial Results 168
10.2.24 Oct 28, 2024: ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call 169
10.2.25 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 169
10.2.26 Oct 23, 2024: electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024 170
10.2.27 Oct 23, 2024: MSA Safety Announces Third Quarter 2024 Results 170
10.2.28 Oct 22, 2024: Masimo to Report Third Quarter 2024 Financial Results after Market Close on Tuesday, November 5 171
10.2.29 Oct 22, 2024: Philip Morris International Posts 2024 Q3 and First Nine-Months Results 172
10.2.30 Oct 21, 2024: Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update 176
10.2.31 Oct 21, 2024: Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call 176
10.2.32 Oct 18, 2024: Getinge Releases Interim Report July-September 2024 177
10.2.33 Oct 17, 2024: Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results 177
10.2.34 Oct 16, 2024: Lilly Confirms Date and Conference Call for Third-Quarter 2024 Financial Results Announcement 177
10.2.35 Oct 16, 2024: Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors 178
10.2.36 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results 178
10.2.37 Oct 09, 2024: Dentsply Sirona to Host Third Quarter Conference Call on November 7th 178
10.2.38 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 178
10.2.39 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results 179
10.2.40 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 179
10.2.41 Aug 28, 2024: Newegg Commerce Posts Results for Six Months Ended June 30, 2024 179
10.2.42 Aug 27, 2024: Electromed Announces Record Fiscal Year 2024 Financial Results 180
10.2.43 Aug 15, 2024: Memorial Sloan Kettering Cancer Center Issues Statement on Second Quarter 2024 Financial Results 181
10.2.44 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance 182
10.2.45 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 183
10.2.46 Jul 31, 2024: Avanos Medical Announces Second Quarter 2024 Results 184
10.2.47 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance 186
10.2.48 Jul 25, 2024: IRADIMED to Hold 2024 Second Quarter Financial Results Conference Call on August 1st 186
10.2.49 Jul 24, 2024: ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call 186
10.2.50 Jul 24, 2024: MSA Safety Announces Second Quarter 2024 Results 187
10.2.51 Jul 23, 2024: General Motors Reports Q2 2024 Revenue 187
10.2.52 Jul 17, 2024: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024 188
10.2.53 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors 188
10.2.54 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024 188
10.2.55 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024 188
10.2.56 May 07, 2024: Kimball Electronics Reports Q3 Results; Company Announces Renewed Strategic Focus, Including Expected Divestiture of the Automation, Test & Measurement Business 188
10.2.57 May 02, 2024: IRadimed Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share 189
10.2.58 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin 190
10.2.59 Apr 29, 2024: MSA Safety Announces First Quarter 2024 Results and Upcoming Investor Events 191
10.2.60 Apr 26, 2024: Mitsubishi Electric Announces Consolidated Financial Results for Fiscal 2024 192
10.3 Government and Public Interest 192
10.3.1 Apr 07, 2025: United States of America tariff update 192
10.3.2 Feb 21, 2025: Sleep Apnea Treatment Part Two: Oral Appliances, Upper Airway Surgery, and Hypoglossal Nerve Stimulation 192
10.3.3 Feb 17, 2025: Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference 194
10.3.4 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 194
10.3.5 Jan 29, 2025: Soleno Therapeutics to Participate in Upcoming February Investor Conferences 194
10.3.6 Jan 17, 2025: FDA Roundup: January 17, 2025 194
10.3.7 Jan 16, 2025: Medical Device Supply Chain Vulnerabilities and the Public Health Impact They Have on Our Most Vulnerable Patients 196
10.3.8 Dec 18, 2024: Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference 198
10.3.9 Nov 26, 2024: Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference 198
10.3.10 Nov 20, 2024: Oncopeptides Invited to Present Data on OPDC-3 in Acute Myeloid Leukemia at the American Society of Hematology Meeting 198
10.3.11 Nov 13, 2024: Masimo to Present in Stifel 2024 Healthcare Conference 199
10.3.12 Nov 12, 2024: Baxter to Present at Stifel 2024 Healthcare Conference 199
10.3.13 Sep 04, 2024: electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 199
10.3.14 Aug 28, 2024: Baxter to Present at 2024 Wells Fargo Healthcare Conference 199
10.3.15 Aug 27, 2024: AdaptHealth to Participate in the Baird 2024 Global Healthcare Conference 199
10.3.16 Aug 21, 2024: Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference 200
10.3.17 Aug 08, 2024: AdaptHealth to Participate in the Canaccord Genuity 44th Annual Growth Conference 200
10.3.18 Jun 20, 2024: Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA Takeaways 200
10.3.19 Jun 03, 2024: Electromed to Participate in the 2024 Sidoti June Small-Cap Virtual Conference 200
10.3.20 Jun 03, 2024: Kimball Electronics Appoints New Treasurer 200
10.3.21 May 22, 2024: AdaptHealth to Participate in the UBS Healthcare Services Cape Cod Summit 201
10.3.22 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics 201
10.3.23 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference 202
10.3.24 Apr 29, 2024: MSA Safety Announces First Quarter 2024 Results and Upcoming Investor Events 202
10.3.25 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024 203
10.4 Legal And Regulatory 203
10.4.1 Mar 10, 2025: Medwin France Receives 510(K) Clearance For pilotTLS ECG Catheter Tip Location System 203
10.4.2 Mar 08, 2025: Medtronic Prevail Paclitaxel-Coated Balloon Catheter Shows Positive Performance in Swedish Coronary Angiography and Angioplasty Registry 203
10.4.3 Feb 24, 2025: American Society of Anesthesiologists Submits Request to Court Seeking Dismissal of AANA's Nondiscrimination Suit 204
10.4.4 Dec 10, 2024: BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction 205
10.4.5 Jul 19, 2024: Inspire Medical Systems Announces CE Mark Certification to the European Medical Device Regulation for Inspire Therapy 206
10.4.6 Apr 30, 2024: Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire 206
10.4.7 Apr 30, 2024: Inside Information, Optomed Aurora with AEYE has Received FDA Clearance in the US 207
10.5 Other Significant Developments 208
10.5.1 Feb 27, 2025: BIOTRONIK Driving the Future of Active Device Business 208
10.5.2 Jan 13, 2025: Clearview Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform 208
10.5.3 Dec 12, 2024: Sunrise, a Leading Sleep Diagnostics Company, Expands U.S. Presence With Innovative At Home Care Solutions 209
10.5.4 Nov 21, 2024: Merck Data of MK-3543 at the ASH 2024 Promising Hematology Pipeline with Diverse Range of Investigational Assets and Novel Modalities 209
10.5.5 Nov 19, 2024: 4DMedical Wins Three-Year Commercial Contract With UCSD Health 210
10.5.6 Jun 12, 2024: Remmie Health Awarded NIH SBIR Phase 2 Grant for AI Ear-Nose-Throat (ENT) Diagnostic Assistance Platform 211
10.5.7 May 29, 2024: Novel Technology for Sleep Apnea Therapy to be Introduced in Record-Breaking Webinar 211
10.6 Product News 212
10.6.1 Apr 16, 2025: PDS Health Announces Launch of PDS Health Technologies 212
10.6.2 Mar 25, 2025: Sleep Number Launches Breatheiq 212
10.6.3 Mar 25, 2025: Endotracheal Tube Recall: Smiths Medical Removes Intubation Oral/Nasal Endotracheal Tubes Due To Smaller Than Expected Tube Diameter That May Cause Underventilation 213
10.6.4 Mar 19, 2025: New Global Study Finds: Sleep Apnea Patients who use CPAP Live Longer 214
10.6.5 Mar 13, 2025: Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients 214
10.6.6 Mar 11, 2025: Resmed Announces Comprehensive Brand Evolution 215
10.6.7 Feb 12, 2025: First Ever Large-Scale Study Linking Nasal Anatomy to Allergy Symptoms, Unveiled at Leading Allergy, Asthma and Immunology Conference 215
10.6.8 Jan 24, 2025: Feinstein Institutes Reveals Brain Changes Seen Years Before Parkinson’s Symptoms in Sleep Disorder Patients 216
10.6.9 Jan 23, 2025: New CMS Quality Measure Tied to GLP-1 Use and Pulmonary Aspiration Is Driven by NAPSI Innovation 216
10.6.10 Jan 09, 2025: Getinge to be Cincinnati Children’s Anesthesia Fleet Provider 217
10.6.11 Jan 06, 2025: CES 2025: Dianyx Innovations Reinvents Sleep Apnea Treatment and Concussion Monitoring with AI-Driven Oral Appliance 217
10.6.12 Oct 16, 2024: When It's Not a Drill: Dräger's New OXY SR Cap III Offers Life-saving Escape for Underground Workers 218
10.6.13 Sep 30, 2024: ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health 219
10.6.14 Sep 17, 2024: SoundHealth Unveils SONUCast, the First-Ever Real-Time Personalized Allergy Forecast Based on Facial Anatomy and Air Quality 219
10.6.15 Sep 11, 2024: Wearable Lung Patch Uses Deep Learning to Detect Asthma and COPD 220
10.6.16 Sep 10, 2024: Vaping Expected to Increase COPD Health and Economic Burden by 2050 222
10.6.17 Aug 20, 2024: Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency And Accuracy To Help Optimize Patient Care 223
10.6.18 Jul 23, 2024: University Hospitals Implants First-in-Human Patient-Specific 3D Printed Tracheal T-tube 223
10.6.19 Jul 09, 2024: Do Not Use Medtronic Nim Standard and Contact Emg Endotracheal Tubes – Letter to Health Care Providers 224
10.6.20 Jul 05, 2024: Update : Philips Respironics Recall of Several Models of CPAP and BiLevel PAP Machines and Mechanical Ventilators 225
10.6.21 Jul 02, 2024: InventHelp Inventor Develops New Pain Relief Pad (CNC-1012) 226
10.6.22 Jun 21, 2024: Cleveland Clinic Study Shows Weight Loss Surgery Cuts Risk of Heart Complications and Death in Patients with Obstructive Sleep Apnea and Obesity 227
10.6.23 Jun 11, 2024: Endotracheal Tube Recall: Medline Industries Removes Medline Sub-G Endotracheal Tube with Subglottic Suctioning due to Detachment or Tearing of the Inflation Tube from the Main Tube 228
10.6.24 Jun 04, 2024: Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio 228
10.6.25 Jun 02, 2024: Women with Sleep Apnea a Focus of ResMed Research at SLEEP 2022 229
10.6.26 May 31, 2024: Medline Industries Issues Nationwide Recall of SubG Endotracheal Tube with Subglottic Suction 229
10.6.27 May 16, 2024: Liberate Bio Announces Presentation To Update On Advancements On Their Raptor Lnp Platform 230
10.6.28 May 16, 2024: ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy 230
10.7 Research And Development 231
10.7.1 Feb 19, 2025: University of Delaware: Advancing Lung Research 231
10.7.2 May 24, 2024: Georgia Tech Researchers Develop Wireless Monitoring Patch System to Detect Sleep Apnea at Home 232
10.8 Strategy And Business Planning 233
10.8.1 Mar 25, 2025: GEM HEALTH Announces Partnership With Sleep Number 233
10.8.2 Mar 11, 2025: Boehringer Ingelheim, Cognizant Launch Unified Cloud Platform 234
10.8.3 Feb 25, 2025: Amino Health Announces Partnership With GEM SLEEP 234
10.8.4 Jan 23, 2025: USME and Zopec Medical Enter Into Partnership 234
10.8.5 Dec 10, 2024: Alveo Technologies and Fraunhofer Enter Into Partnership 235
10.8.6 Nov 04, 2024: World’s First Ear-Worn AI/ML Platform for Physiological Monitoring Introduced by Nokia Bell Labs and Cambridge Future Tech 235
10.8.7 Oct 09, 2024: Verastem Oncology Announces RAMP 201 Data Evaluating Avutometinib Plus Defactinib in Ovarian Cancer at the IGCS 2024 Annual Meeting 236
10.8.8 Jul 24, 2024: B. Braun Medical Announces First U.S. Conversion to NRFit Connectors 237
11 Appendix 239
11.1 Research Methodology 239
11.1.1 Coverage 240
11.1.2 Secondary Research 240
11.1.3 Primary Research 240
11.1.4 Market Modeling and Forecasting 241
11.1.5 Company Share Analysis 242
11.1.6 Distribution Share Analysis 242
11.1.7 Benchmarking 243
11.2 GlobalData Consulting 243
11.3 Contact Us 243
11.4 Disclaimer 244
